Clinical Trials Browser

Interventional × Breast Neoplasms, Male × sargramostim × Clear all

NCT00524277 2020-03-30

Vaccine Therapy in Treating Patients With Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT02019524 2020-03-18

J65

Phase 1 Completed

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Male

NCT00343109 2020-02-12

Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT01355393 2020-02-10

Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer

Phase 1/2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Phase 2 Completed

50 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00791037 2017-05-25

Vaccine Therapy in Treating Patients With Stage IV Breast Cancer

Phase 1/2 Completed

23 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00028496 2013-01-25

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Phase 1 Completed

BreastGastrointestinalGenitourinaryHead & Neck

Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Carcinoma, Medullary, Breast Neoplasms, Male